CFO transition
Teladoc Health, Inc. CFO transition: Michael Grasher to succeed Charles Divita, III
Teladoc Health, Inc. reported in a Form 8-K filed August 31, 2026 that Michael Grasher will succeed Charles Divita, III as Chief Financial Officer, effective August 31, 2026.
In the filing's words
Effective August 31, 2026, Teladoc Health, Inc. (the “Company”) hired Michael Grasher as its Chief Financial Officer. Charles Divita, III, who served as the Company’s interim principal financial officer, will continue as Chief Executive Officer.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Teladoc Health, Inc. (TDOC) |
|---|---|
| Event | Transition |
| Incoming | Michael Grasher |
| Outgoing | Charles Divita, III |
| Title in the filing | Chief Financial Officer |
| Effective | August 31, 2026 |
| 8-K filed | August 31, 2026 |
| Internal promotion | No |
| Prior role (per filing) | Chief Financial Officer, IFG Companies |
| SEC CIK | 0001477449 |
Teladoc Health, Inc. reported this change in a Form 8-K, Item 5.02, filed August 31, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Michael Grasher? Send a correction with the primary source.